Sweden-based Alba Health provides an asynchronous gut testing service for children. The company’s product incorporates AI and is based on research carried out by the company in partnership with the University of Helsinki’s Health and Early Life Microbiota (HELMi) cohort. The study tracked the gut health of 1,000+ children over six years and collected 10,000+ microbiome samples and 50,000 data points on lifestyle and health outcomes. Based on this research, the company’s product includes an at-home testing kit, which allows parents to take gut microbe samples from children and send it back to Alba’s labs for analysis. Once the analyzed results are shared, parents can schedule virtual consultations with dieticians to create personalized care plans. The company’s platform additionally includes a range of evidence-based educational content and an online community for parents to discuss gut health-related topics and best practices.
Funding and financials
In June 2023, the company raised USD 2 million in a pre-seed funding round led by Voima Ventures, along with participation from other venture capital firms. The raised funds were set aside to launch the company’s digital gut health solution for children.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.